These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6195295)

  • 1. A tumor-associated antigen specific for human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Hayden GE; Basten A
    J Exp Med; 1983 Nov; 158(5):1769-74. PubMed ID: 6195295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
    Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
    Abe M; Goto T; Wolfenbarger D; Weiss DT; Solomon A
    Hybridoma; 1993 Aug; 12(4):475-83. PubMed ID: 8244419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of an epitope on human free kappa-light chains and on a cytoplasmic component in activated T cells.
    Walker KZ; Hayden GE; Goodnow CC; Boux HA; Adams E; Basten A; Raison RL
    J Immunol; 1985 Feb; 134(2):1059-64. PubMed ID: 2578149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agent.
    Walker KZ; Boux HA; Hayden GE; Goodnow CC; Raison RL
    Adv Exp Med Biol; 1985; 186():833-41. PubMed ID: 3931433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
    Hagner G
    Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rat model system for radioimmunodetection of kappa myeloma antigen on malignant B cells.
    Walker KZ; Seymour-Munn K; Keech FK; Axiak SM; Bautovich GJ; Morris JG; Basten A
    Eur J Nucl Med; 1986; 12(9):461-7. PubMed ID: 3102238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
    Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
    Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
    Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
    Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies.
    Springer TA; Bhattacharya A; Cardoza JT; Sanchez-Madrid F
    Hybridoma; 1982; 1(3):257-73. PubMed ID: 6208128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
    Turesson I; Grubb A
    Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against rat immunoglobulin kappa chains.
    Lanier LL; Gutman GA; Lewis DE; Griswold ST; Warner NL
    Hybridoma; 1982; 1(2):125-31. PubMed ID: 6821397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
    van Velzen JF; van den Blink D; Bloem AC
    Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a unique conformational epitope on free immunoglobulin kappa light chains that is recognized by an antibody with therapeutic potential.
    Hutchinson AT; Alexova R; Bockhorni V; Ramsland PA; Jones DR; Jennings CV; Broady K; Edmundson AB; Raison RL
    Mol Immunol; 2011 May; 48(9-10):1245-52. PubMed ID: 21466897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
    Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
    Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody against sheep kappa light chain.
    Foley RC; Raison RL; Beh KJ
    Hybridoma; 1991 Aug; 10(4):507-15. PubMed ID: 1937501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies specific for the b5 allotype of rabbit kappa light chains.
    McCormack WT; Roux KH
    Hybridoma; 1983; 2(1):97-107. PubMed ID: 6432680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.